1
Open
[.]
2
Close
[.]
3
Allotment
—
4
Listing
[.]
Issue Size
1,91,51,400 shares (agg. up to ₹[.] Cr)
Listing Date
[.]
✦ AI Insight
Restated Financials (₹ Cr.)
| Period Ended | 31 Dec 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 699.31 | 615.82 | 483.50 | 395.67 |
| Total Income | 1,523.11 | 1,636.06 | 1,497.33 | 1,435.20 |
| Profit After Tax | 25.47 | 14.29 | 16.01 | 10.04 |
| EBITDA | 39.97 | 35.45 | 29.62 | 13.09 |
| NET Worth | 157.76 | 132.29 | 108.58 | 93.32 |
| Reserves and Surplus | 138.65 | 114.52 | 108.58 | 93.32 |
| Total Borrowing | 244.21 | 207.68 | 147.22 | 62.01 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Sudeep Pharma Ltd. | Mainboard | ₹895.00 Cr | ₹593 | 47.61 | ₹774.15 | +30.55% | ₹1,104.10 |
| Gem Aromatics Ltd. | Mainboard | ₹451.25 Cr | ₹325 | 28.52 | ₹319.05 | -1.83% | ₹170.10 |
| Devson Catalyst Ltd. | SME | ₹42.34 Cr | ₹118 | 9.66 | ₹205.95 | +74.53% | ₹276.75 |
| Vahh Chemicals Ltd. | SME | ₹13.45 Cr | ₹60 | 7.15 | ₹66.50 | +10.83% | ₹52.25 |
| Biopol Chemicals Ltd. | SME | ₹31.26 Cr | ₹108 | 19.73 | ₹105.50 | -2.31% | ₹99.70 |
| Neochem Bio Solutions Ltd. | SME | ₹44.97 Cr | ₹98 | 15.85 | ₹111.80 | +14.08% | ₹95.65 |
| Speb Adhesives Ltd. | SME | ₹33.73 Cr | ₹56 | 16.73 | ₹57.00 | +1.79% | ₹87.65 |
| SK Minerals & Additives Ltd. | SME | ₹41.15 Cr | ₹127 | 10.45 | ₹152.25 | +19.88% | ₹430.65 |
| Shlokka Dyes Ltd. | SME | ₹57.79 Cr | ₹91 | 13.69 | ₹85.50 | -6.04% | ₹23.25 |
| Snehaa Organics Ltd. | SME | ₹32.68 Cr | ₹122 | 12.47 | ₹115.90 | -5.00% | ₹45.85 |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Investment in Altra Agro-Chem Private Limited, Associate Company, by way of subscription to equity shares for making it Subsidiary | 61.72 |
| 2 | Investment in Altra Pharma-Chem Private Limited, Associate Company, by way of subscription to equity shares for making it Subsidiary | 21.64 |
| 3 | Repayment or pre-payment, in in part or full of certain borrowings availed by the Company from financial institutions | 25.00 |
| 4 | General Corporate Purposes | |
| Total | 108.37 |
About Ujin Pharma IPO
Incorporated in May 2024, Ujin Pharma Limited is a chemical distribution and supply company engaged in the trading and distribution of solvents, specialty chemicals, acids, monomers, pharmaceutical raw materials, and nutraceuticals. The company serves a diverse customer base across pharmaceuticals, agrochemicals, specialty chemicals, petrochemicals, automotive, paints & coatings, printing inks, packaging, and industrial sectors. With over two decades of industry experience through its predecessor partnership firm, the company has built a strong sourcing network comprising 1,277 suppliers and distribution infrastructure supported by warehouses in Bhiwandi (Maharashtra) and Kandla (Gujarat). During the last three financial years and the period ended December 31, 2025, the company supplied approximately 8.53 lakh MT of chemical products to over 3,000 customers. Through its subsidiary, Shiv Shakti Oxalate Private Limited (SSOPL), the company has expanded into value-added chemical processing activities including solvent recycling, solvent recovery, and printing chemical manufacturing. SSOPL operates a manufacturing facility at Kurkumbh, Pune, equipped with distillation, extraction, blen
Contact Details
Ujin Pharma Ltd. Address610/6th floor Neelkanth Corporate Park,Kirol Road,Vidyavihar West,Mumbai, Maharashtra, 400086+91 83558 47502cs@ujinpharma.comVisit Website